Supplementary Figure 7 from Human Breast Cancer Cells Harboring a Gatekeeper T798M Mutation in HER2 Overexpress EGFR Ligands and Are Sensitive to Dual Inhibition of EGFR and HER2

Supplementary Figure 7 - PDF file 282K, Inhibition of P-Akt in xenografts treated with trastuzumab plus/minus lapatinib